Safety and pharmacokinetics of an oral p38 MAP kinase inhibitor (BIRB 796 BS), administered twice daily for 14 days to healthy volunteers

作者: SH Polmar , Chan-Loi Yong , Chester C Wood , Hildegrad Staehle , A Gupta

DOI: 10.1016/S0091-6749(02)81293-3

关键词:

摘要:

参考文章(0)